Author

Timothy P. Mayo

Observed name: T Mayo

Observed institutions: Medical University of South Carolina, Washington University in St. Louis, AdventHealth Celebration, Barnes-Jewish West County Hospital, AdventHealth

OpenAlex ID: A5113085271

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2023 · O Abani, A Abbas, et al. · The Lancet Diabetes & Endocrinology · 41

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial

2024 · Saul N Faust, Richard Haynes, et al. · The Lancet Child & Adolescent Health · 39

Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases · 12

A Qualitative Exploration of Stakeholders’ Preferences for Early-Stage Rectal Cancer Treatment

2023 · Merrill E. Rubens, Timothy P. Mayo, et al. · Annals of Surgery Open · 5

Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases

Intraoperative Methadone Use in Patients Undergoing Minimally Invasive Colorectal Surgical Procedures

2023 · Nathan S. Kau, Kasim L. Mirza, et al. · World Journal of Colorectal Surgery

Works count: 6

Citation count: 97

H-index: 4

I10-index: 3